C-reactive protein is associated with the progression of acute embolic stroke in rabbit model

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 4, 2012, Pages 301-307

  Yu, Qi ^a   Lin, Yan ^a   Yang, Peigang ^a   Wang, Yanli ^a   Zhao, Sihai ^a   Yang, Penghui ^a   Fan, Jianglin ^b   Liu, Enqi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Biomarker; C reactive protein; Cerebral ischemia; Rabbit; Stroke

Indexed keywords

C REACTIVE PROTEIN; MONOCLONAL ANTIBODY; BIOLOGICAL MARKER; NERVE PROTEIN;

ACUTE EMBOLIC STROKE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN LEVEL; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; BRAIN; DISEASE MODEL; EMBOLISM; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; RABBIT; STROKE;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN INFARCTION; C-REACTIVE PROTEIN; DISEASE MODELS, ANIMAL; EMBOLISM; GENE EXPRESSION REGULATION; MALE; NERVE TISSUE PROTEINS; RABBITS; STROKE;

EID: 84865141283     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0627-0     Document Type: Article

References (25)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917): 868-874. doi:10.1038/nature01323
2. Koenig W, Lowel H, Baumert J, Meisinger C (2004) C-reactive protein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 109(11):1349-1353. doi: 10.1161/01.CIR.0000120707.98922.E3
3. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363-369
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336(14):973-979. doi:10.1056/NEJM199704033361401
5. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12):836-843. doi:10.1056/NEJM200003233421202
6. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 332(10):635-641. doi:10.1056/ NEJM199503093321003
7. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR (1999) C-reactive protein and outcome after ischemic stroke. Stroke 30(5):981-985
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347(20):1557-1565. doi:10.1056/NEJMoa021993
9. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D'Agostino RB, Franzblau C, Wilson PW (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32(11):2575-2579
10. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D (2002) Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 33(10):2459-2464
11. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr., Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373(9670):1175-1182. doi: 10.1016/S0140-6736(09)60447-5
12. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K, Tracy RP (2003) C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107(15): 2016-2020. doi:10.1161/01.CIR.0000065228. 20100.F7
13. Ford ES, Giles WH (2000) Serum C-reactive protein and selfreported stroke: findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol 20(4):1052-1056
14. Benes V, Zabramski JM, Boston M, Puca A, Spetzler RF (1990) Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected]. Stroke 21(11):1594-1599
15. Purdy PD, Devous MD Sr., Batjer HH, White CL 3rd, Meyer Y, Samson DS (1989) Microfibrillar collagen model of canine cerebral infarction. Stroke 20(10):1361-1367
16. Zhang C, Zheng H, Yu Q, Yang P, Li Y, Cheng F, Fan J, Liu E (2010)Apractical method for quantifying atherosclerotic lesions in rabbits. J Comp Pathol 142(2-3):122-128. doi:10.1016/j.jcpa. 2009.08.159
17. Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke. Lancet 371(9624):1612-1623. doi:10.1016/S0140-6736(08)606 94-7
18. Lindsberg PJ, Grau AJ (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34(10):2518-2532. doi: 10.1161/01.STR.0000089015. 51603.CC
19. Worthmann H, Tryc AB, Deb M, Goldbecker A, Ma YT, Tountopoulou A, Lichtinghagen R, Weissenborn K (2010) Linking infection and inflammation in acute ischemic stroke. Ann N Y Acad Sci 1207:116-122. doi:10.1111/j.1749-6632.20 10.05738.x
20. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Sander K, Smith CJ, Stefanini A, Weber D (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36(6): 1316-1329. doi:10.1161/01.STR. 0000165929.78756.ed
21. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2. doi:10.1186/1471-2377-4-2
22. Rothenburg LS, Herrmann N, Swardfager W, Black SE, Tennen G, Kiss A, Gladstone DJ, Ween J, Snaiderman A, Lanctot KL (2010) The relationship between inflammatory markers and post stroke cognitive impairment. J Geriatr Psychiatry Neurol 23(3):199-205. doi:10.1177/0891988710373598
23. Slevin M, Matou-Nasri S, Turu M, Luque A, Rovira N, Badimon L, Boluda S, Potempa L, Sanfeliu C, de Vera N, Krupinski J (2010) Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol 20(1):151-165. doi:10.1111/j.1750-3639.2008.00256.x
24. Yasojima K, Schwab C, McGeer EG, McGeer PL (2000) Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 887(1):80-89
25. Koike T, Kitajima S, Yu Y, Nishijima K, Zhang J, Ozaki Y, Morimoto M, Watanabe T, Bhakdi S, Asada Y, Chen YE, Fan J (2009) Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation 120(21):2088-2094. doi: 10.1161/CIRCULATIONAHA.109.872796